More articles from 5.1 Airway Pharmacology and Treatment

Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Peter M.A. Calverley, Emiel F.M. Wouters, Helen Finnigan, Kay Tetzlaff, Helgo Magnussen

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4067; DOI: 10.1183/13993003.congress-2016.PA4067
A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
L.J. Holmes, D. Ryan, G.A. Tavernier, R.M. Niven

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4101; DOI: 10.1183/13993003.congress-2016.PA4101
Audit of bronchial thermoplasty patients who did not complete their treatment session as planned
K. Hince, L.J. Holmes, G. McCumesky, C. Ustabasi, R.M. Niven, D. Ryan

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4121; DOI: 10.1183/13993003.congress-2016.PA4121
Optimizing patient experience of nebulizer treatments
Ross Hatley, Louise Rowe, Ian Rabbetts, Filippo Quadrelli

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4082; DOI: 10.1183/13993003.congress-2016.PA4082
Onbrace: A real-life evaluation of indacaterol maintenance treatment for COPD
Walter Vincken, Antoine Poskin, Sandra Gurdain, Jan Van Schoor, Stefaan Vancayzeele, Paul Van den Brande

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4074; DOI: 10.1183/13993003.congress-2016.PA4074
Bronchodilator use in Latin America primary care: The PUMA study
Maria Montes De Oca, Maria Victorina Lopez Varela, Jose Jardim, Roberto Stirvulov, Filip Surmont

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4076; DOI: 10.1183/13993003.congress-2016.PA4076
Effect of systemic inflammation and multi-morbidity on outcome of adult-onset asthma
Pinja Ilmarinen, Leena E. Tuomisto, Onni Niemelä, Joanna Danielsson, Jussi Haanpää, Terhi Kankaanranta, Hannu Kankaanranta

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4113; DOI: 10.1183/13993003.congress-2016.PA4113
The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment
Iryna Savelikhina, Oleksandr Varunkiv, Mykola Ostrovskyy, Mariana Kulynych-Miskiv, Kseniia Ostrovska

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4072; DOI: 10.1183/13993003.congress-2016.PA4072
The 'real-life' long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta
Caroline Gouder, Rachelle Asciak, Stephen Montefort

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4115; DOI: 10.1183/13993003.congress-2016.PA4115
Reslizumab (RES) in asthma patients (pts) with severe eosinophilic asthma stratified by GINA asthma steps 4 and 5: Analysis of two phase 3, placebo (PBO)-controlled trials
Guy Brusselle, Jennifer McElhattan, Janice Canvin, Roland Buhl

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4107; DOI: 10.1183/13993003.congress-2016.PA4107

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages